medicines
- Health
Exploration of GHRP-2 Peptide
Growth Hormone Releasing Peptide-2 (GHRP-2) belongs to a class of synthetic peptides known as secretagogues. These compounds are designed to stimulate the release of endogenous growth hormone (GH) from the pituitary gland. As part of the GHRP family, GHRP-2 may exhibit unique properties that distinguish it from other peptides in its class. This article explores the speculative mechanisms, molecular interactions,…
- Health
Exploring Selank peptide in infection research
Researchers have examined the synthetic peptide Selank for possible impacts on the immune system. In this piece, we examine how Selank may affect infections. It has been postulated that Selank may be able to modify immunological responses, improve antiviral activity, and impact inflammatory processes. These theories and the function of the peptide in infection control need further investigation. The heptapeptide…
- Health
Revolutionary treatments offer new hope in battle against leprosy
Leprosy, an ailment of ancient origin that has been subject to substantial misconceptions, has impacted human societies for millennia, frequently shrouded in stigma and apprehension. Although it has persistently figured in public discourse, a notable void exists in the general populace’s comprehension of its treatment modalities. Modern medicine has achieved considerable progress in this domain; nonetheless, the inquiry persists: what…
- Business News
FTI urges support for Thai SMEs to boost global herbal medicine exports
The Federation of Thai Industries (FTI) urged the government to strengthen its support for small and medium-sized enterprises (SMEs) involved in herbal development and production. The move is aimed at enhancing their global competitiveness and propelling Thailand into the top 10 herbal medicine exporters worldwide. SMEs in the sector are currently struggling with insufficient funds for research and development, and…
- World News
EU to unveil major pharmaceutical reform for cheaper drugs and faster access
The European Union is set to announce significant reforms to its pharmaceutical regulations today, aiming to reduce costs, prevent drug shortages, and expedite the introduction of new medicines. These changes represent the EU’s most extensive overhaul of pharmaceutical legislation in two decades, partly inspired by the benefits of more streamlined processes, joint action, and improved transparency observed during the Covid-19…
